Blocking GLP-1r corrected hypoglycemia in a group of subjects with GB-related postprandial neuroglycopenic hypoglycemia [45], and the contribution of GLP-1 to postprandial insulin secretion was larger in affected individuals compared to asymptomatic RYGB subjects. This evidence concerns the gene GLP1R and Hypoglycemia.